[Doping for the brain]
- PMID: 29209802
- DOI: 10.1007/s00391-017-1351-y
[Doping for the brain]
Abstract
The enhancement of physical and cognitive abilities (i. e. concentration, vigilance, memory) has always been desirable for humans. The term pharmacological neuroenhancement refers to the use of legal or nonprescription psychoactive substances by healthy subjects with the intention of cognitive enhancement. To give the most prominent example, caffeine serves worldwide as a natural stimulant. Brain doping, however, specifies the use of illegal substances or prescription drugs beyond approval with the purpose of cognitive enhancement. Only amphetamines, methylphenidate and modafinil have significant effects on attentiveness, concentration and alertness, whereas other substances, such as anti-dementia drugs or anti-depressants failed to demonstrate cognitive enhancement in healthy subjects.
Keywords: Brain doping; Cognition; Enhancement; Neuroenhancement; Psychotropic drugs.
Similar articles
-
[Pharmacological neuroenhancement and brain doping : Chances and risks].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Aug;53(8):853-9. doi: 10.1007/s00103-010-1105-0. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010. PMID: 20700786 Review. German.
-
What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement.PLoS One. 2012;7(6):e40047. doi: 10.1371/journal.pone.0040047. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768218 Free PMC article.
-
Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine.Psychopharmacology (Berl). 2021 Feb;238(2):441-451. doi: 10.1007/s00213-020-05691-w. Epub 2020 Nov 17. Psychopharmacology (Berl). 2021. PMID: 33201262 Free PMC article. Clinical Trial.
-
The Case of Pharmacological Neuroenhancement: Medical, Judicial and Ethical Aspects from a German Perspective.Pharmacopsychiatry. 2015 Nov;48(7):256-64. doi: 10.1055/s-0035-1559640. Epub 2015 Aug 7. Pharmacopsychiatry. 2015. PMID: 26252723 Review.
-
[Pharmacological cognitive enhancement from a perspective of misuse and addiction].Fortschr Neurol Psychiatr. 2015 Feb;83(2):83-90. doi: 10.1055/s-0034-1398935. Epub 2015 Feb 27. Fortschr Neurol Psychiatr. 2015. PMID: 25723772 Review. German.
Cited by
-
Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.Neural Plast. 2021 Jan 13;2021:8823383. doi: 10.1155/2021/8823383. eCollection 2021. Neural Plast. 2021. PMID: 33519929 Free PMC article. Review.
-
Neuroenhancement: State of the Art and Future Perspectives.Clin Neuropsychiatry. 2021 Jun;18(3):137-169. doi: 10.36131/cnfioritieditore20210303. Clin Neuropsychiatry. 2021. PMID: 34909030 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical